The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metabolites as mediator for alleviating adverse effects in chemotherapy: A new finding from a recent study of Japanese traditional Kampo medicine, rikkunshito (RKT).
 
Hiroyuki Suzuki
Consulting or Advisory Role - AstraZeneca Japan
Speakers' Bureau - AstraZeneca Japan; Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical; Roche
Research Funding - AstraZeneca Japan; Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical; Roche
 
Takuya Inoue
No Relationships to Disclose
 
Hironori Takagi
No Relationships to Disclose
 
Masayuki Watanabe
No Relationships to Disclose
 
Yuki Ozaki
No Relationships to Disclose
 
Satoshi Muto
No Relationships to Disclose
 
Naoyuki Okabe
No Relationships to Disclose
 
Takeo Hasegawa
No Relationships to Disclose
 
Yutaka Shio
No Relationships to Disclose
 
Hiroyuki Minemura
No Relationships to Disclose
 
Kenya Kanazawa
No Relationships to Disclose
 
Katsuya Ohbuchi
Employment - Tsumura & Co.
 
Takahisa Fukushima
Employment - Tsumura & Co.